Aminopyrimidine compounds and methods of use

Details for Australian Patent Application No. 2005316312 (hide)

Owner Amgen, Inc.

Inventors Brennan, Paul Edward; Rainbeau, Elizabeth; Paras, Nick A.; Demorin, Frenel Fils; Smith, Adrian Leonard; Liu, Gang; Retz, Daniel Martin

Agent Shelston IP

Pub. Number AU-B-2005316312

PCT Pub. Number WO2006/066172

Priority 60/636,604 17.12.04 US

Filing date 16 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 22 October 2009

International Classifications

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

C07D 333/16 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/066172 Priority application(s): WO2006/066172

20 December 2007 Amendment Made

  The nature of the amendment is: Add coinventor Rainbeau, Elizabeth

22 October 2009 Application Accepted

  Published as AU-B-2005316312

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316313-Novel MCH receptor antagonists

2005316310-A soy protein isolate and process for its manufacture